Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS)
The Prostate · 2024
DOI: 10.1002/pros.24656 ↗At a glance
Übersichtsarbeit in The Prostate, 2024. Written by Dana Cavanaugh and 5 co-authors. Institution: Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Major MEDLINE topics: Prostatic Hyperplasia, Metabolic Syndrome, Lower Urinary Tract Symptoms. Cited 12 times so far (Crossref); 104 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, NINR NIH HHS.
Abstract (original language)
Background
Benign prostatic hyperplasia (BPH) is the most common urologic disease in aging males, affecting 50% of men over 50 and up to 80% of men over 80 years old. Its negative impact on health‐related quality of life implores further investigation into its risk factors and strategies for effective management. Although the exact molecular mechanisms underlying pathophysiological onset of BPH are poorly defined, the current hypothesized contributors to BPH and lower urinary tract symptoms (LUTS) include aging, inflammation, metabolic syndrome, and hormonal changes. These processes are indirectly influenced by circadian rhythm disruption. In this article, we review the recent evidence on the potential association of light changes/circadian rhythm disruption and the onset of BPH and impact on treatment.
Methods
A narrative literature review was conducted using PubMed and Google Scholar to identify supporting evidence. The articles referenced ranged from 1975 to 2023.
Results
A clear relationship between BPH/LUTS and circadian rhythm disruption is yet to be established. However, common mediators influence both diseases, including proinflammatory states, metabolic syndrome, and hormonal regulation that can be asserted to circadian disruption. Some studies have identified a possible relationship between general LUTS and sleep disturbance, but little research has been done on the medical management of these diseases and how circadian rhythm disruption further affects treatment outcomes.
Conclusions
There is evidence to implicate a relationship between BPH/LUTS and circadian rhythm disruptions. However, there is scarce literature on potential specific link in medical management of the disease and treatment outcomes with circadian rhythm disruption. Further study is warranted to provide BPH patients with insights into circadian rhythm directed appropriate interventions.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Tisch Cancer Institute at Mount Sinai, New York, New York, USA.
- Prostate Cancer Research Center, Faculty of Medicine and Health Technology and FiCanMid, Tampere University, Tampere, Finland.
- Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
- Department of Population Health Science and Policy, Light and Health Research Center, Mount Sinai Health, New York, New York, USA.
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID profiles: Dana Cavanaugh, Natasha Kyprianou
Funding
- NCI NIH HHS
- NINR NIH HHS
Cite
APA
Cavanaugh, D., Urbanucci, A., Mohamed, N. E., Tewari, A. K., Figueiro, M., & Kyprianou, N. (2024). Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS). The Prostate. https://doi.org/10.1002/pros.24656
Vancouver
Cavanaugh D, Urbanucci A, Mohamed NE, Tewari AK, Figueiro M, Kyprianou N. Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS). The Prostate. 2024. doi:10.1002/pros.24656
BibTeX
@article{Cavanaugh2024,
author = {Cavanaugh, Dana and Urbanucci, Alfonso and Mohamed, Nihal E and Tewari, Ashutosh K and Figueiro, Mariana and Kyprianou, Natasha},
title = {Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS)},
journal = {The Prostate},
year = {2024},
doi = {10.1002/pros.24656}
}
EUVIMED